Element Biosciences Stock
Element Biosciences is focused on innovating genetic analysis tools for the research and diagnostic markets.
Sign up for SecondMarket™ to view the market and buy or sell Element Biosciences Stock
Buy + SellElement Biosciences Funding
Sign up to gain insights into Element Biosciences funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the DataDate | Financing Round | Amount | Price per share* | Valuation* |
---|---|---|---|---|
Jun 28, 2024 | Series D | 267.17M | ||
Jul 09, 2021 | Series C | 276.00M | ||
Jun 26, 2020 | Series B | 30.00M | ||
Apr 30, 2020 | Series B | 80.30M | ||
Nov 26, 2018 | Series A | 15.00M | ||
Oct 27, 2017 | Series Seed | 5.11M |
See Element Biosciences Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Element Biosciences Stock Valuation + Share Prices
View real-time Tape D™ data on Element Biosciences stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get StartedElement Biosciences Management Team
Director
Bryan E. Roberts
Director
Jim Tananbaum
Co-founder, CTO, SVP of R&D
Michael Previte
Director
John R. Stuelpnagel
Co-founder, CEO, Director
Molly Henderson
Element Biosciences Major Investors
RA Capital Management LLC
Meritech Capital Partners
Wellington Management Company LLP
T. Rowe Price Group, Inc.
T. Rowe Price Group, Inc.
Foresite Capital
Foresight Ventures
Fidelity Management & Research Company
JS Capital Management LLC
Logos Capital
Venrock, Inc.
Venrock, Inc.
T. Rowe Price Associates, Inc.
T. Rowe Price Associates, Inc.
Samsung
Janus Henderson
Alexandria Venture Investments
Counterpoint Global